ON
← Back to feed
Dinosaur auction in New York: Gus is expected to fetch up to $30 million Researchers are alarmed
CH🏛️ PoliticsCenter12 hr. ago

Dinosaur auction in New York: Gus is expected to fetch up to $30 million Researchers are alarmed

The Swiss newspaper Tages-Anzeiger reports on an upcoming auction at Sotheby's in New York where a large T-Rex skeleton, referred to as 'Gus,' is expected to sell for up to $30 million. Paleontologists are expressing concern that this ancient fossil, dating back 67 million years, could be lost to scientific research if it is sold privately rather than being made available for study.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

1 reports

Tages-Anzeiger logoTages-AnzeigerIndependentCenter12 hr. ago
Dinosaur auction in New York: Gus is expected to fetch up to $30 million Researchers are alarmed

The Swiss newspaper Tages-Anzeiger reports on an upcoming auction at Sotheby's in New York where a large T-Rex skeleton, referred to as 'Gus,' is expected to sell for up to $30 million. Paleontologists are expressing concern that this ancient fossil, dating back 67 million years, could be lost to scientific research if it is sold privately rather than being made available for study.

Bias read (Center): The article presents information about a high-value fossil auction without overtly endorsing or criticizing either the sale or the researchers' concerns. It frames the situation neutrally by stating the potential financial value and the scientists' worries without taking a clear ideological stance.

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories